Oppenheimer & CO Inc Trans Medics Group, Inc. Transaction History

Oppenheimer & CO Inc

$7.23 Billion
Q2 2025

A detailed history of Oppenheimer & CO Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 117,370 shares of TMDX stock, worth $13.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

117,370

Previous 78,002 50.47%

Holding current value

$13.9 Million

Previous $5.25 Million 199.75%

% of portfolio

0.22%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$67.67 - $143.04 $2.66 Million - $5.63 Million	39,368 Added 50.47%	117,370 $15.7 Million
Q1 2025 Apr 22, 2025	BUY	$56.73 - $79.42 $827,009 - $1.16 Million	14,578 Added 22.98%	78,002 $5.25 Million
Q4 2024 Feb 04, 2025	BUY	$59.28 - $144.9 $1.1 Million - $2.69 Million	18,531 Added 41.28%	63,424 $3.95 Million
Q3 2024 Nov 05, 2024	BUY	$135.68 - $176.11 $372,848 - $483,950	2,748 Added 6.52%	44,893 $7.05 Million
Q2 2024 Aug 07, 2024	BUY	$72.62 - $150.62 $1.13 Million - $2.35 Million	15,575 Added 58.62%	42,145 $6.35 Million
Q1 2024 May 06, 2024	BUY	$70.86 - $89.93 $1.15 Million - $1.46 Million	16,214 Added 156.57%	26,570 $1.96 Million
Q4 2023 Feb 13, 2024	BUY	$36.74 - $81.08 $50,150 - $110,674	1,365 Added 15.18%	10,356 $817,000
Q3 2023 Nov 07, 2023	SELL	$53.47 - $96.07 $192,438 - $345,755	-3,599 Reduced 28.59%	8,991 $492,000
Q2 2023 Aug 02, 2023	BUY	$66.23 - $88.73 $76,959 - $103,104	1,162 Added 10.17%	12,590 $1.06 Million
Q1 2023 May 10, 2023	BUY	$53.63 - $82.33 $85,915 - $131,892	1,602 Added 16.3%	11,428 $865,000
Q4 2022 Feb 07, 2023	SELL	$39.08 - $64.29 $105,320 - $173,261	-2,695 Reduced 21.52%	9,826 $606,000
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $94,080 - $166,190	2,981 Added 31.25%	12,521 $523,000
Q1 2022 May 12, 2022	BUY	$12.58 - $26.94 $120,013 - $257,007	9,540 New	9,540 $257,000

Others Institutions Holding TMDX

# of Institutions

414

Shares Held

29.8M

Call Options Held

1.19M

Put Options Held

777K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.76B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Trans Medics Group, Inc. Transaction History